Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ·Healthcare·Biotechnology
$3.51
+1.30%
Mkt Cap $207.43M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$0.20 | -$0.10 | +50.00% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.22 | -$0.21 | +4.55% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.23 | -$0.13 | +43.48% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.28 | -$0.08 | +71.43% | — | — |
| Q1 2025 Mar 20, 2025 | — | $192.00K | — | -$0.32 | -$0.64 | -100.00% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.30 | -$0.32 | -6.67% | — | — |
| Q3 2024 Aug 19, 2024 | — | — | — | -$0.31 | -$0.32 | -3.23% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.37 | -$0.34 | +8.11% | — | — |
| Q1 2024 Mar 28, 2024 | — | $560.00K | — | -$0.38 | -$0.29 | +23.68% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.41 | -$0.35 | +14.63% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.47 | -$0.40 | +14.89% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.71 | -$0.75 | -5.63% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.70 | -$0.68 | +2.86% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.68 | -$0.73 | -7.35% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.72 | -$0.65 | +9.72% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.67 | -$0.69 | -2.99% | — | — |
| Q1 2022 Mar 24, 2022 | — | $120 | — | -$0.83 | -$0.59 | +28.92% | — | — |
| Q4 2021 Nov 11, 2021 | — | — | — | -$0.67 | -$0.66 | +1.49% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.58 | -$0.50 | +13.79% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.37 | -$0.57 | -54.05% | — | — |